Highly prevalent TERT promoter mutations in aggressive thyroid cancers

Highly prevalentTERTpromoter mutations in bladder cancer and glioblastoma

(2013) Xiaoli Liu et al.   CELL CYCLE

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

(2013) Mingzhao Xing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Progress in molecular-based management of differentiated thyroid cancer

(2013) Mingzhao Xing et al.   LANCET

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

(2012) Robert C. Smallridge et al.   THYROID

Telomerase and the search for the end of cancer

(2012) Simone Mocellin et al.   TRENDS IN MOLECULAR MEDICINE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Papillary Carcinoma Tall Cell Variant (TCV): A Review

(2010) Virginia A. LiVolsi   ENDOCRINE PATHOLOGY

Telomeres and Thyroid Cancer

(2009) Marco Capezzone et al.   CURRENT GENOMICS